|
Market Closed -
Nasdaq
23:00:00 28/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 5.020 USD | -2.71% |
|
+7.73% | -22.29% |
| 08-12 | Aquestive Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-11 | Aquestive Therapeutics Q2 Loss Widens, Revenue Rises | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Other Pharmaceuticals | -2.71% | +7.73% | -22.29% | +33.16% | +24.26% | 630M |  | |  |
- Stock Market
- Stocks
- AQST Stock
- Charts Aquestive Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
